# BWX Technologies, Inc.: financial statements, quarterly

BWXT · NYSE · CIK 1486957 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bwxt.md) · [Financials](/companies/bwxt/financials.md) · [Filings](/companies/bwxt/filings.md) · [Insiders](/companies/bwxt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bwxt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [590](/filings/0001486957-25-000008.md) | [726](/filings/0001486957-25-000008.md) | [604](/filings/0001486957-26-000007.md) | [681](/filings/0001486957-26-000007.md) | [672](/filings/0001486957-26-000007.md) | [746](/filings/0001486957-26-000007.md) | [682](/filings/0001486957-26-000028.md) | [764](/filings/0001486957-26-000044.md) | [866](/filings/0001486957-26-000007.md) | [886](/filings/0001486957-26-000007.md) | [860](/filings/0001486957-26-000028.md) | [902](/filings/0001486957-26-000044.md) |
| Cost of revenue | $m | [436](/filings/0001486957-23-000042.md) | [537 d](/filings/0001486957-26-000007.md) | [455](/filings/0001486957-25-000026.md) | [513](/filings/0001486957-25-000052.md) | [508](/filings/0001486957-25-000059.md) | [572 d](/filings/0001486957-26-000007.md) | [517](/filings/0001486957-26-000028.md) | [573](/filings/0001486957-26-000044.md) | [677](/filings/0001486957-25-000059.md) | [699 d](/filings/0001486957-26-000007.md) | [663](/filings/0001486957-26-000028.md) | [699](/filings/0001486957-26-000044.md) |
| Research and development | $m | [1.2](/filings/0001486957-24-000046.md) | [1.7 d](/filings/0001486957-26-000007.md) | [1.5](/filings/0001486957-25-000026.md) | [1.3](/filings/0001486957-25-000052.md) | [2.1](/filings/0001486957-25-000059.md) | [2.6 d](/filings/0001486957-26-000007.md) | [2.0](/filings/0001486957-26-000028.md) | [4.6](/filings/0001486957-26-000044.md) | [3.5](/filings/0001486957-25-000059.md) | [3.8 d](/filings/0001486957-26-000007.md) | [4.1](/filings/0001486957-26-000028.md) | [4.2](/filings/0001486957-26-000044.md) |
| Selling, general and administrative | $m | [79.8](/filings/0001486957-24-000046.md) | [74.6 d](/filings/0001486957-26-000007.md) | [67.4](/filings/0001486957-25-000026.md) | [79.8](/filings/0001486957-25-000052.md) | [80.8](/filings/0001486957-25-000059.md) | [90.7 d](/filings/0001486957-26-000007.md) | [87.6](/filings/0001486957-26-000028.md) | [103](/filings/0001486957-26-000044.md) | [93.4](/filings/0001486957-25-000059.md) | [111 d](/filings/0001486957-26-000007.md) | [108](/filings/0001486957-26-000028.md) | [108](/filings/0001486957-26-000044.md) |
| Operating income | $m | [85.4](/filings/0001486957-25-000008.md) | [123](/filings/0001486957-25-000008.md) | [93.0](/filings/0001486957-26-000007.md) | [98.8](/filings/0001486957-26-000007.md) | [96.6](/filings/0001486957-26-000007.md) | [92.3](/filings/0001486957-26-000007.md) | [96.6](/filings/0001486957-26-000028.md) | [102](/filings/0001486957-26-000044.md) | [113](/filings/0001486957-26-000007.md) | [92.1](/filings/0001486957-26-000007.md) | [107](/filings/0001486957-26-000028.md) | [114](/filings/0001486957-26-000044.md) |
| Interest expense | $m | [12.2](/filings/0001486957-23-000042.md) | [11.8 d](/filings/0001486957-24-000011.md) | [9.6](/filings/0001486957-24-000029.md) | [10.7](/filings/0001486957-25-000052.md) | [9.9](/filings/0001486957-25-000059.md) | [9.3 d](/filings/0001486957-26-000007.md) | [8.0](/filings/0001486957-26-000028.md) | [11.7](/filings/0001486957-26-000044.md) | [14.0](/filings/0001486957-25-000059.md) | [10.5 d](/filings/0001486957-26-000007.md) | [4.7](/filings/0001486957-26-000028.md) | [5.3](/filings/0001486957-26-000044.md) |
| Income tax | $m | [17.8](/filings/0001486957-24-000046.md) | [19.3 d](/filings/0001486957-26-000007.md) | [19.8](/filings/0001486957-25-000026.md) | [18.6](/filings/0001486957-25-000052.md) | [21.0](/filings/0001486957-25-000059.md) | [7.0 d](/filings/0001486957-26-000007.md) | [16.3](/filings/0001486957-26-000028.md) | [19.3](/filings/0001486957-26-000044.md) | [25.4](/filings/0001486957-25-000059.md) | [7.3 d](/filings/0001486957-26-000007.md) | [16.1](/filings/0001486957-26-000028.md) | [24.5](/filings/0001486957-26-000044.md) |
| Net income | $m | [60.3](/filings/0001486957-25-000008.md) | [65.9](/filings/0001486957-25-000008.md) | [68.5](/filings/0001486957-26-000007.md) | [73.0](/filings/0001486957-26-000007.md) | [69.5](/filings/0001486957-26-000007.md) | [71.0](/filings/0001486957-26-000007.md) | [75.5](/filings/0001486957-26-000028.md) | [78.4](/filings/0001486957-26-000044.md) | [82.1](/filings/0001486957-26-000007.md) | [93.0](/filings/0001486957-26-000007.md) | [91.1](/filings/0001486957-26-000028.md) | [89.0](/filings/0001486957-26-000044.md) |
| Diluted EPS | $ per share | [0.66](/filings/0001486957-25-000008.md) | [0.72](/filings/0001486957-25-000008.md) | [0.75](/filings/0001486957-26-000007.md) | [0.79](/filings/0001486957-26-000007.md) | [0.76](/filings/0001486957-26-000007.md) | [0.77](/filings/0001486957-26-000007.md) | [0.82](/filings/0001486957-26-000028.md) | [0.85](/filings/0001486957-26-000044.md) | [0.89](/filings/0001486957-26-000007.md) | [1.01](/filings/0001486957-26-000007.md) | [0.99](/filings/0001486957-26-000028.md) | [0.97](/filings/0001486957-26-000044.md) |
| Basic EPS | $ per share | [0.66](/filings/0001486957-25-000008.md) | [0.72](/filings/0001486957-25-000008.md) | [0.75](/filings/0001486957-26-000007.md) | [0.80](/filings/0001486957-26-000007.md) | [0.76](/filings/0001486957-26-000007.md) | [0.78](/filings/0001486957-26-000007.md) | [0.82](/filings/0001486957-26-000028.md) | [0.86](/filings/0001486957-26-000044.md) | [0.90](/filings/0001486957-26-000007.md) | [1.02](/filings/0001486957-26-000007.md) | [0.99](/filings/0001486957-26-000028.md) | [0.97](/filings/0001486957-26-000044.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue, us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [50.2](/filings/0001486957-23-000042.md) | [75.8](/filings/0001486957-25-000008.md) | [45.9](/filings/0001486957-24-000029.md) | [48.3](/filings/0001486957-24-000042.md) | [35.5](/filings/0001486957-24-000046.md) | [74.1](/filings/0001486957-26-000007.md) | [55.4](/filings/0001486957-25-000026.md) | [37.0](/filings/0001486957-25-000052.md) | [79.6](/filings/0001486957-25-000059.md) | [500](/filings/0001486957-26-000044.md) | [512](/filings/0001486957-26-000028.md) | [608](/filings/0001486957-26-000044.md) |
| Current assets | $m | [878](/filings/0001486957-23-000042.md) | [818](/filings/0001486957-25-000008.md) | [865](/filings/0001486957-24-000029.md) | [910](/filings/0001486957-24-000042.md) | [983](/filings/0001486957-24-000046.md) | [930](/filings/0001486957-26-000007.md) | [976](/filings/0001486957-25-000026.md) | [997](/filings/0001486957-25-000052.md) | [1,104](/filings/0001486957-25-000059.md) | [1,560](/filings/0001486957-26-000044.md) | [1,616](/filings/0001486957-26-000028.md) | [1,710](/filings/0001486957-26-000044.md) |
| Total assets | $m | [2,777](/filings/0001486957-23-000042.md) | [2,747](/filings/0001486957-25-000008.md) | [2,788](/filings/0001486957-24-000029.md) | [2,841](/filings/0001486957-24-000042.md) | [2,947](/filings/0001486957-24-000046.md) | [2,870](/filings/0001486957-26-000007.md) | [3,054](/filings/0001486957-25-000026.md) | [3,699](/filings/0001486957-25-000052.md) | [3,782](/filings/0001486957-25-000059.md) | [4,271](/filings/0001486957-26-000044.md) | [4,325](/filings/0001486957-26-000028.md) | [4,423](/filings/0001486957-26-000044.md) |
| Current liabilities | $m | [351](/filings/0001486957-23-000042.md) | [375](/filings/0001486957-25-000008.md) | [387](/filings/0001486957-24-000029.md) | [409](/filings/0001486957-24-000042.md) | [437](/filings/0001486957-24-000046.md) | [474](/filings/0001486957-26-000007.md) | [484](/filings/0001486957-25-000026.md) | [590](/filings/0001486957-25-000052.md) | [647](/filings/0001486957-25-000059.md) | [672](/filings/0001486957-26-000044.md) | [674](/filings/0001486957-26-000028.md) | [713](/filings/0001486957-26-000044.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | [1,790](/filings/0001486957-26-000007.md) | not reported | not reported | not reported | [3,038](/filings/0001486957-26-000044.md) | [3,045](/filings/0001486957-26-000028.md) | [3,089](/filings/0001486957-26-000044.md) |
| Long-term debt | $m | [1,334](/filings/0001486957-23-000042.md) | [1,203](/filings/0001486957-25-000008.md) | [1,221](/filings/0001486957-24-000029.md) | [1,203](/filings/0001486957-24-000042.md) | [1,221](/filings/0001486957-24-000046.md) | [1,043](/filings/0001486957-26-000007.md) | [1,185](/filings/0001486957-25-000026.md) | [1,520](/filings/0001486957-25-000052.md) | [1,497](/filings/0001486957-25-000059.md) | [2,016](/filings/0001486957-26-000044.md) | [2,018](/filings/0001486957-26-000028.md) | [2,020](/filings/0001486957-26-000044.md) |
| Current portion of debt | $m | [6.3](/filings/0001486957-23-000042.md) | [6.3](/filings/0001486957-25-000008.md) | [7.8](/filings/0001486957-24-000029.md) | [9.4](/filings/0001486957-24-000042.md) | [10.9](/filings/0001486957-24-000046.md) | [12.5](/filings/0001486957-26-000007.md) | [12.5](/filings/0001486957-25-000026.md) | [12.5](/filings/0001486957-25-000052.md) | [12.5](/filings/0001486957-25-000059.md) | [0.0](/filings/0001486957-26-000007.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [872](/filings/0001486957-23-000042.md) | [933](/filings/0001486957-25-000008.md) | [946](/filings/0001486957-24-000029.md) | [998](/filings/0001486957-24-000042.md) | [1,059](/filings/0001486957-24-000046.md) | [1,081](/filings/0001486957-26-000007.md) | [1,100](/filings/0001486957-25-000026.md) | [1,184](/filings/0001486957-25-000052.md) | [1,242](/filings/0001486957-25-000059.md) | [1,232](/filings/0001486957-26-000044.md) | [1,280](/filings/0001486957-26-000028.md) | [1,334](/filings/0001486957-26-000044.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [74.3 d](/filings/0001486957-24-000046.md) | [222 d](/filings/0001486957-26-000007.md) | [33.0](/filings/0001486957-25-000026.md) | [65.9 d](/filings/0001486957-25-000052.md) | [32.6 d](/filings/0001486957-25-000059.md) | [277 d](/filings/0001486957-26-000007.md) | [50.7](/filings/0001486957-26-000028.md) | [159 d](/filings/0001486957-26-000044.md) | [143 d](/filings/0001486957-25-000059.md) | [127 d](/filings/0001486957-26-000007.md) | [92.6](/filings/0001486957-26-000028.md) | [156 d](/filings/0001486957-26-000044.md) |
| Capital expenditure | $m | [30.9 d](/filings/0001486957-24-000046.md) | [50.8 d](/filings/0001486957-26-000007.md) | [30.4](/filings/0001486957-25-000026.md) | [30.4 d](/filings/0001486957-25-000052.md) | [40.3 d](/filings/0001486957-25-000059.md) | [52.5 d](/filings/0001486957-26-000007.md) | [33.4](/filings/0001486957-26-000028.md) | [32.7 d](/filings/0001486957-26-000044.md) | [48.3 d](/filings/0001486957-25-000059.md) | [70.2 d](/filings/0001486957-26-000007.md) | [42.5](/filings/0001486957-26-000028.md) | [41.4 d](/filings/0001486957-26-000044.md) |
| Dividends paid | $m | [21.1 d](/filings/0001486957-24-000046.md) | [21.1 d](/filings/0001486957-26-000007.md) | [22.4](/filings/0001486957-25-000026.md) | [22.0 d](/filings/0001486957-25-000052.md) | [22.0 d](/filings/0001486957-25-000059.md) | [22.0 d](/filings/0001486957-26-000007.md) | [23.7](/filings/0001486957-26-000028.md) | [23.1 d](/filings/0001486957-26-000044.md) | [22.9 d](/filings/0001486957-25-000059.md) | [22.8 d](/filings/0001486957-26-000007.md) | [25.8](/filings/0001486957-26-000028.md) | [24.7 d](/filings/0001486957-26-000044.md) |
| Share repurchases | $m | [0.0 d](/filings/0001486957-24-000046.md) | [0.0 d](/filings/0001486957-26-000007.md) | [20.0](/filings/0001486957-25-000026.md) | [0.0 d](/filings/0001486957-25-000052.md) | [0.0 d](/filings/0001486957-25-000059.md) | [0.0 d](/filings/0001486957-26-000007.md) | [30.0](/filings/0001486957-26-000028.md) | [0.0 d](/filings/0001486957-26-000044.md) | [0.0 d](/filings/0001486957-25-000059.md) | [0.0 d](/filings/0001486957-26-000007.md) | [0.0](/filings/0001486957-26-000028.md) | [0.0 d](/filings/0001486957-26-000044.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [91.7](/filings/0001486957-23-000042.md) | [91.8](/filings/0001486957-24-000029.md) | [91.8](/filings/0001486957-24-000042.md) | [91.9](/filings/0001486957-24-000046.md) | [91.9](/filings/0001486957-25-000026.md) | [91.8](/filings/0001486957-25-000052.md) | [91.9](/filings/0001486957-25-000059.md) | [91.9](/filings/0001486957-26-000028.md) | [91.7](/filings/0001486957-26-000044.md) | [91.8](/filings/0001486957-25-000059.md) | [91.9](/filings/0001486957-26-000028.md) | [92.0](/filings/0001486957-26-000044.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 91,621,980 at 2026-07-31, from the cover of the [10-Q/A filed 2026-08-05](/filings/0001486957-26-000044.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.